T-Cell Receptor Sequence Optimization Using RL and AVIB Models
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Optimizing T-cell receptor (TCR) sequences for enhanced affinity and conformational flexibility is challenging due to the complexity of the TCR complex, requiring significant computational resources and time.
Innovation Solution
A reinforcement-learning framework using variational information bottleneck with attention of experts (AVIB classifiers) and proximal policy optimization (PPO) models is employed to fine-tune TCR sequences, clustering them based on k-mer profiles to achieve higher binding scores and validate biological functional potency.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If structural biology approaches are used to model TCR binding, then the model can provide structural insights, but the conformational flexibility of the TCR complex makes binding difficult to model
Solution Approach 1:
The patent replaces traditional structural biology approaches with machine learning models that process sequence data to predict TCR binding affinity. The AVIB classifier and reinforcement learning framework substitute physical structural modeling with computational sequence analysis, avoiding the complexities of modeling conformational flexibility while achieving accurate binding predictions.
Solution Approach 2:
The patent transforms the problem from modeling three-dimensional structural flexibility to analyzing sequence space parameters. By representing TCRs as sequences and using k-mer profiles, the approach changes the parameter space from structural coordinates to sequence composition features, making the problem tractable through machine learning.
2Manufacturing precision
If machine learning methods are used to design TCR of higher affinity, then the affinity can be improved, but the computational resources and time required increase significantly
Solution Approach 1:
The patent performs preliminary clustering of TCR sequences based on k-mer profiles before applying reinforcement learning. This pre-organization of the sequence space allows the reinforcement learning algorithm to focus on optimizing within smaller, more manageable clusters rather than searching the entire sequence space, significantly reducing computational time while maintaining high affinity optimization.
Solution Approach 2:
The patent segments the TCR sequence optimization problem into multiple independent clusters based on k-mer similarity. Each cluster represents a subset of sequences with similar characteristics, allowing parallel processing and reducing the overall computational burden while achieving high affinity designs through focused optimization within each segment.
3Reliability
If TCR sequences are optimized for higher affinity, then the antigen recognition improves, but the conformational flexibility may be reduced
Solution Approach 1:
The patent applies local quality optimization by focusing mutations and sequence modifications specifically on the complementarity-determining regions (CDRs) that directly contact the antigen, while leaving the framework regions that maintain structural flexibility relatively unchanged. This allows improved antigen recognition through localized sequence optimization without compromising overall conformational flexibility.
Data Source
AI summary
Systems and methods for particularly t-cell receptor complex optimization with reinforcement learning. Classifiers using variational information bottleneck with attention of experts (AVIB classifiers) can be fine-tuned for different representations of desired t-cell receptor (TCR) sequences for a patient. Proximal policy optimization (PPO) models can be trained with reinforcement learning using the AVIB classifiers as reward functions to achieve higher affinity in generating interaction sequences for the desired TCR sequences through automated decision making. The interaction sequences can be clustered based on k-mer profiles to select the interaction sequences having highest binding scores in each cluster as final sequences. A biological functional potency of the final sequences can be validated.